---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-26-000009"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:30:59.145210+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics reports record 2025 revenue $236.3M (+15% YoY); Q4 first positive free cash flow $9.8M

## Summary
- Record FY2025 revenue $236.3M, up 15% from $204.7M in 2024.
- Q4 2025 revenue $61.6M (+17% YoY); net loss per share $0.43 vs $0.69.
- Adjusted EBITDA FY2025 $14.8M vs $8.5M; Q4 adjusted EBITDA $4.8M vs $3.0M.
- Generated $9.8M free cash flow in Q4, first positive FCF quarter; cash $62.9M.
- FY2026 guidance: revenue $262-266M (11-13% growth), adjusted EBITDA ~$25M, breakeven cash flow.

## SEC filing metadata
- accession: 0001425450-26-000009
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000009/0001425450-26-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000009/kids-20260226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-26-000009
- JSON: https://secwatch.observer/filing/0001425450-26-000009.json
- Plain text: https://secwatch.observer/filing/0001425450-26-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.